Search Within

Tarun Kewalramani

Formats
  1. Meeting Abstract (38)
  2. Journal Article (24)
  3. Book Section (1)
Groups
  1. Department of Medicine (55)
  2. Hematologic Malignancies, Division of (53)
  3. Center for Hematologic Malignancies (47)
  4. Lymphoma (31)
  5. Survivorship Research (27)
  6. Radiation Oncology, Department of (24)

More Groups

People
  1. Stephen Nimer (40)
  2. Craig Moskowitz (33)
  3. Andrew Zelenetz (29)
  4. Joachim Yahalom (23)
  5. Julie Feldstein (16)
  6. Raymond Comenzo (16)

More People

Years
  1. 2010 (3)
  2. 2009 (3)
  3. 2008 (6)
  4. 2007 (8)
  5. 2006 (7)
  6. 2005 (7)

More Years

Publications
  1. Blood (35)
  2. Bone Marrow Transplantation (5)
  3. British Journal of Haematology (5)
  4. Journal of Clinical Oncology (4)
  5. Biology of Blood and Marrow Transplantation (2)
  6. International Journal of Radiation Oncology, Biology, Physics (2)

More Publications

Publishers
  1. American Society of Hematology (35)
  2. Nature Publishing Group (6)
  3. John Wiley & Sons (5)
  4. American Society of Clinical Oncology (4)
  5. Elsevier Inc. (4)
  6. Oxford University Press (3)

More Publishers

Results (63)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evaluation of single-dose palifermin to reduce oral mucositis (OM) in fractionated total body irradiation (fTBI) and high dose (HD) chemotherapy with autologous peripheral blood progenitor cell (PBPC) transplantation
    Meeting Abstract

    Shea, T. C.; Kewalramani, T.; Mun, Y.; Jayne, G.; Dreiling, L. K.
    Blood (2006)

    Fulltext@MSK | Save
  • High-dose chemotherapy with autologous stem cell rescue (ASCR) for newly diagnosed anaplastic oligodendrogliomal tumors: Preliminary report of an oligodendroglioma study group trial
    Meeting Abstract

    Mohile, N. A.; Lassman, A. B.; Louis, D. N.; Kewalramani, T.; Forsyth, P.; Stewart, D.; Paleologos, N.; Raizer, J. J.; Deangelis, L. M.; Cairncross, J. G.; more...
    Neuro-Oncology (2006)

    Fulltext@MSK | Save
  • Relapsed and refractory primary mediastinal diffuse large B-cell lymphoma: Outcome with ICE-based treatment
    Meeting Abstract

    Hamlin, P. A.; Dickson, M.; Kewalramani, T.; Horwitz, S. M.; Portlock, C. S.; Yahalom, J.; Zelenetz, A. D.; Moskowitz, C. H.
    Blood (2006)

    Fulltext@MSK | Save
  • The serum IL-12:IL-6 ratio reliably distinguishes infectious from non-infectious causes of fever during autologous stem cell transplantation
    Journal Article

    Tuma, R. A.; Almyroudis, N. G. ; Sohn, S. J.; Panageas, K.; Rice, R. D.; Galinkin, D.; Blain, M.; Montefusco, M.; Pamer, E. G.; Nimer, S. D.; more...
    Cytotherapy (2006)

    Fulltext@MSK | Save
  • Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma
    Journal Article

    Kewalramani, T.; Zelenetz, A. D.; Teruya-Feldstein, J.; Hamlin, P.; Yahalom, J.; Horwitz, S.; Nimer, S. D.; Moskowitz, C. H.
    British Journal of Haematology (2006)

    Fulltext@MSK | Save
  • Doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective well tolerated initial therapy for multiple myeloma
    Journal Article

    Hassoun, H.; Reich, L.; Klimek, V. M.; Dhodapkar, M.; Cohen, A.; Kewalramani, T.; Zimman, R.; Drake, L.; Riedel, E. R.; Hedvat, C. V.; more...
    British Journal of Haematology (2006)

    Fulltext@MSK | Save
  • Results of a phase I/II trial adding carmustine (300mg/m 2) to melphalan (200mg/m 2) in multiple myeloma patients undergoing autologous stem cell transplantation
    Journal Article

    Comenzo, R. L.; Hassoun, H.; Kewalramani, T.; Klimek, V.; Dhodapkar, M.; Reich, L.; Teruya-Feldstein, J.; Fleisher, M.; Filippa, D.; Nimer, S. D.
    Leukemia (2006)

    Fulltext@MSK | Save
  • Second-line therapy with ICE followed by high dose therapy and autologous stem cell transplantation for relapsed/refractory peripheral T-Cell lymphomas: Minimal benefit when analyzed by intent to treat
    Meeting Abstract

    Horwitz, S.; Moskowitz, C.; Kewalramani, T.; Hamlin, P.; Straus, D.; O'connor, O.; Noy, A.; Portlock, C.; Nimer, S.; Palomba, M. L.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • The serum free light chain ratio after one or two cycles of treatment is highly predictive of the magnitude of final response in patients undergoing initial treatment for multiple myeloma
    Meeting Abstract

    Hassoun, H.; Reich, L.; Klimek, V. M.; Dhodapkar, M.; Cohen, A.; Kewalramani, T.; Riedel, E. R.; Hedvat, C. V.; Teruya-Feldstein, J.; Filippa, D. A.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Risk-adapted dosing of melphalan for systemic AL amyloidosis (AL) lowers treatment-related mortality: Early death but not post-3 month survival is linked to cardiac involvement
    Meeting Abstract

    Comenzo, R. L.; Zhou, P.; Hassoun, H.; Kewalramani, T.; Klimek, V.; Cohen, A. D.; Ferrand, S. K.; Dhodapkar, M.; Feldstein, J. T.; Fleisher, M.; more...
    Blood (2005)

    Fulltext@MSK | Save